glutamic acid has been researched along with Mole, Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajouaou, A; Dankort, D; Horlings, HM; Kortman, PC; McMahon, M; Meissl, K; Michaloglou, C; Mooi, WJ; Peeper, DS; Possik, PA; Smit, MA; Vredeveld, LC | 1 |
| Barany, F; Elenitsas, R; Seykora, J; Turner, DJ; Zirvi, MA | 1 |
2 other study(ies) available for glutamic acid and Mole, Skin
| Article | Year |
|---|---|
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Topics: Amino Acid Substitution; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p15; Enzyme Activation; Fibroblasts; Glutamic Acid; Humans; Melanocytes; Melanoma; Nevus; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms; Valine | 2012 |
Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Topics: Base Sequence; DNA; DNA Mutational Analysis; Dysplastic Nevus Syndrome; Glutamic Acid; Humans; Ligases; Melanocytes; Melanoma; Molecular Sequence Data; Mutation; Nevus; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Skin Neoplasms; Valine | 2005 |